Navigation Links
Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
Date:11/5/2009

SEATTLE, Nov. 5 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced financial results for its third quarter and nine months ended Sept. 30, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO)

Third Quarter and Nine Months 2009 Financial Results

Revenue for the third quarter and nine months ended Sept. 30, 2009, was $4.5 million and $12.8 million, respectively, compared with $3.8 million and $12.2 million, respectively, in 2008. Revenues were primarily earned through Trubion's strategic collaborations with Pfizer Inc. and Facet Biotech Corporation (announced Aug. 28, 2009).

Of the $12.8 million in revenue Trubion recognized during the first nine months of 2009, $8.5 million was collaborative research funding from the Pfizer collaboration and $3.6 million for recognition of the $40 million upfront fee received from Wyeth prior to its acquisition by Pfizer. Revenue earned in the nine months ended Sept. 30, 2009, also included $643,000 that was earned through the Facet collaboration. This is composed of $191,000 for recognition of the $20 million upfront fee and $1.4 million equity premium, and $452,000 in collaborative research funding.

This is compared with revenue of $12.2 million recognized in the first nine months of 2008, which was composed of $8.1 million for collaboration research funding from the Pfizer collaboration and $4.1 million for recognition of the $40 million upfront fee paid by Wyeth prior to its acquisition by Pfizer.

Total operating expenses for the third quarter and first
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
2. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
3. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
4. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
5. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
6. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
7. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
8. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
11. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 "Copay ... inflate sales of brand drugs among patients with ... according to a new report  from the ... of the Inspector General (OIG). Federal anti-kickback laws prohibit ... that are subsidized by the federal government. ...
(Date:9/19/2014)... Today, iHealth Lab Inc. announced it has secured ... its first institutional round of funding. The strategic investment ... accelerate growth and innovation, and invest in additional sales ... Ventures will join iHealth,s board of directors, bringing added ... "We are very pleased to have Xiaomi ...
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... Feb. 20, 2011 NxStage® Medical, Inc. ... innovative dialysis products, today announced the latest interim results ... in overall quality of life benefits, significant improvement in ... Legs Syndrome (RLS) symptoms experienced by patients after 12 ...
... One year to the day of its introduction, the ... to its official company launch.  "Starting a new company takes ... about the industry and our place in it and now ... healthcare." Dr. McCord is no stranger to healthcare. ...
Cached Medicine Technology:New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 2New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 3New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period 4
(Date:9/21/2014)... 2014 Best Cheap Hosting USA, one ... Arvixe, Bluehost and GreenGeeks are the best Reseller hosting ... good reseller hosting supplier. Actually, these companies have outperformed ... customer support. People can get the best web hosting ... , According to the manager, reseller hosting is a ...
(Date:9/21/2014)... del Rio, Colorado (PRWEB) September 21, 2014 ... Vail, Colorado, ten teams of disabled and able-bodied athletes ... cycles, and completed a ropes course in pursuit of ... Challenge from national non-profit World T.E.A.M. Sports, disabilities ... participating athletes who successfully completed the three stage event. ...
(Date:9/21/2014)... California (PRWEB) September 21, 2014 Developers ... plugins have announced a new transition plugin entitled ... Vol. 3 delivers high quality transitions that will add ... said Christina Austin, CEO of Pixel Film Studios. “Blurring ... is a definite game changer.” , Transpack Vol. 3 ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and retailer, has ... In addition, the company has launched a special offer on ... to benefit all of its big fans. Worldwide people can ... , Along with beautiful party dresses, the company also offers ... its new sexy short prom outfits and purple homecoming gowns ...
(Date:9/20/2014)... David Cooke presented two scientific posters at ASNC ... the clinical benefits of MPI gated studies with 8 ... conjunction with colleagues at Emory University, Cooke studied 121 ... echo (>50%). Each patient had same-day 99mTc low-dose rest ... Toolbox 4.0 was used to analyze the resting ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3
... Yearning is the primary emotion felt after the death of ... depression being the primary// emotion and the one felt most ... from the Harvard Medical School and Yale University School of ... the ‘typical bereaved American’- white, elderly-above 60 years, and who ...
... out with a new scheme- Zero interest rates for improving ... by authorized bodies of plastic surgery as being highly ‘irresponsible’ ... plastic surgery. , Not so, says Transform. ... rise and besides they argue, everyone is familiar with zero ...
... can happen in patients with stroke, and hospital procedures ... error and patients getting hurt, according to a study. ... adverse events and errors within a voluntary and mandatory ... Memorial Hospital at the University of Rochester Medical Center ...
... shows that young transplant patients who lose their insurance ... drugs//, which can increase the risk of losing the ... the March issue of Pediatric Transplantation. ,“Immunosuppressive ... more than $13,000 a year,” says study author Mark ...
... benefits of multiple low-energy treatments, combined with a plasma ... enhance the appearance, in record healing time. These multiple ... session, with reduced healing times. ,"Plasma is ... stripped from atoms to form an ionized gas," the ...
... Archives of Surgery suggests that surgeons portraying skill in ... simulated surgery skills. ,James C. Rosser Jr., ... colleagues asked 33 surgeons (21 residents and 12 attending ... performance at the Rosser Top Gun Laparoscopic Skills and ...
Cached Medicine News:Health News:Yearning -the Most Intense Emotion in Bereavement 2Health News:Learning to Prevent Medical Mistakes in Caring for Stroke Patients 2Health News:Organ Transplant Patients May Die When Insurance for Medicine Runs Out 2Health News:Multiple Low-energy Plasma Skin Treatments Beneficial in Reducing Facial Wrinkles 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: